What does INTEGRAL HEALTH & RESEARCH do?

INTEGRAL HEALTH & RESEARCH is a testing and inspection body in Oud-Heverlee. Private Limited, started on 22 May 2002, 1 establishment.

What is the address of INTEGRAL HEALTH & RESEARCH?

The registered office of INTEGRAL HEALTH & RESEARCH is located at Herpendaalstraat 47, 3053 Oud-Heverlee.

Is INTEGRAL HEALTH & RESEARCH still active?

Yes. According to the CBE (31 October 2026) INTEGRAL HEALTH & RESEARCH is active, legal situation “Normale toestand”, started on 22 May 2002.

Is INTEGRAL HEALTH & RESEARCH registered on Peppol?

Yes, INTEGRAL HEALTH & RESEARCH is registered on the Peppol network with ID 0208:0477577520.

What is the enterprise number of INTEGRAL HEALTH & RESEARCH?

The enterprise number of INTEGRAL HEALTH & RESEARCH is BE0477577520.

When was INTEGRAL HEALTH & RESEARCH founded?

INTEGRAL HEALTH & RESEARCH was founded on 22 May 2002.

Who are the directors of INTEGRAL HEALTH & RESEARCH?

According to the 2025 annual accounts, the directors of INTEGRAL HEALTH & RESEARCH are: Birgit Martens.

Is INTEGRAL HEALTH & RESEARCH a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 22 May 2002; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did INTEGRAL HEALTH & RESEARCH make in 2025?

INTEGRAL HEALTH & RESEARCH posted a profit after taxes of € 87,173 in financial year 2025.

What is the revenue of INTEGRAL HEALTH & RESEARCH?

As a small company, INTEGRAL HEALTH & RESEARCH is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 168,068.

INTEGRAL HEALTH & RESEARCH (Private Limited)

Dossier INTEGRAL HEALTH & RESEARCH, printed on 31 October 2026 from databakkes.be/en/0477577520/integral-health-research. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

INTEGRAL HEALTH & RESEARCH from Oud-Heverlee, company number BE0477577520, closed financial year 2025 with a result of € 87,173 after tax. For that financial year INTEGRAL HEALTH & RESEARCH recorded a gross margin of € 168,068 and equity of € 524,182. Compared with financial year 2024, the result moved from € 106,714 to € 87,173. The company is profitable. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 9, 2026.

What it is worth Growing

€ 524,182

▲ 8% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 87,173

▼ 18% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 202,198

▲ 15% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 48,800 paid out

56 % of the profit went to the shareholders, the rest stayed in the company.

People and assets in 2025

Wage cost

€ 2,158

▲ 13% vs 2024

Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 25,217

▼ 31% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

€ 720

Loans from banks and other lenders, long and short.

Owed to suppliers

€ 1,524

▼ 36% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 9,984

▼ 52% vs 2024

Taxes, VAT and social contributions still to pay.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 127,517 Gross margin 2022: € 127,517 First fiscal year in the series	€ 147,049 Gross margin 2023: € 147,049 ▲ 15% vs 2022 (€ 127,517) Favourable step	€ 183,305 Gross margin 2024: € 183,305 ▲ 25% vs 2023 (€ 147,049) Favourable step	€ 168,068 Gross margin 2025: € 168,068 ▼ 8% vs 2024 (€ 183,305) Unfavourable step	▼ 8%
Profit after taxes	€ 72,175 Profit after taxes 2022: € 72,175 First fiscal year in the series	€ 79,871 Profit after taxes 2023: € 79,871 ▲ 11% vs 2022 (€ 72,175) Favourable step	€ 106,714 Profit after taxes 2024: € 106,714 ▲ 34% vs 2023 (€ 79,871) Favourable step	€ 87,173 Profit after taxes 2025: € 87,173 ▼ 18% vs 2024 (€ 106,714) Unfavourable step	▼ 18%
Equity	€ 395,225 Equity 2022: € 395,225 First fiscal year in the series	€ 426,095 Equity 2023: € 426,095 ▲ 8% vs 2022 (€ 395,225) Favourable step	€ 485,809 Equity 2024: € 485,809 ▲ 14% vs 2023 (€ 426,095) Favourable step	€ 524,182 Equity 2025: € 524,182 ▲ 8% vs 2024 (€ 485,809) Favourable step	▲ 8%
Total debts	€ 42,249 Total debts 2022: € 42,249 First fiscal year in the series	€ 35,464 Total debts 2023: € 35,464 ▼ 16% vs 2022 (€ 42,249) Favourable step	€ 125,440 Total debts 2024: € 125,440 ▲ 254% vs 2023 (€ 35,464) Unfavourable step	€ 146,308 Total debts 2025: € 146,308 ▲ 17% vs 2024 (€ 125,440) Unfavourable step	▲ 17%
Cash	€ 305,246 Cash 2022: € 305,246 First fiscal year in the series	€ 168,820 Cash 2023: € 168,820 ▼ 45% vs 2022 (€ 305,246) Unfavourable step	€ 175,299 Cash 2024: € 175,299 ▲ 4% vs 2023 (€ 168,820) Favourable step	€ 202,198 Cash 2025: € 202,198 ▲ 15% vs 2024 (€ 175,299) Favourable step	▲ 15%
Land & buildings	€ 16,606 Land & buildings 2022: € 16,606 First fiscal year in the series	€ 14,073 Land & buildings 2023: € 14,073 ▼ 15% vs 2022 (€ 16,606) Unchanged	€ 11,540 Land & buildings 2024: € 11,540 ▼ 18% vs 2023 (€ 14,073) Unchanged	€ 9,007 Land & buildings 2025: € 9,007 ▼ 22% vs 2024 (€ 11,540) Unchanged	▼ 22%
Retained profit	€ 376,625 Retained profit 2022: € 376,625 First fiscal year in the series	€ 407,495 Retained profit 2023: € 407,495 ▲ 8% vs 2022 (€ 376,625) Favourable step	€ 467,209 Retained profit 2024: € 467,209 ▲ 15% vs 2023 (€ 407,495) Favourable step	€ 505,582 Retained profit 2025: € 505,582 ▲ 8% vs 2024 (€ 467,209) Favourable step	▲ 8%
Dividend	€ 45,000 Dividend 2022: € 45,000 First fiscal year in the series	€ 128,000 Dividend 2023: € 128,000 ▲ 184% vs 2022 (€ 45,000) Unchanged	€ 47,000 Dividend 2024: € 47,000 ▼ 63% vs 2023 (€ 128,000) Unchanged	€ 48,800 Dividend 2025: € 48,800 ▲ 4% vs 2024 (€ 47,000) Unchanged	▲ 4%
Bank debt	€ 22,835 Bank debt 2022: € 22,835 First fiscal year in the series	€ 11,823 Bank debt 2023: € 11,823 ▼ 48% vs 2022 (€ 22,835) Favourable step	€ 720 Bank debt 2024: € 720 ▼ 94% vs 2023 (€ 11,823) Favourable step	€ 720 Bank debt 2025: € 720 Unchanged (€ 720) Unchanged
Balance sheet total	€ 437,473 Balance sheet total 2022: € 437,473 First fiscal year in the series	€ 461,559 Balance sheet total 2023: € 461,559 ▲ 6% vs 2022 (€ 437,473) Unchanged	€ 611,249 Balance sheet total 2024: € 611,249 ▲ 32% vs 2023 (€ 461,559) Unchanged	€ 670,490 Balance sheet total 2025: € 670,490 ▲ 10% vs 2024 (€ 611,249) Unchanged	▲ 10%

Key figures of INTEGRAL HEALTH & RESEARCH, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to INTEGRAL HEALTH & RESEARCH?

What happened at INTEGRAL HEALTH & RESEARCH in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jul 9, 2026 New annual accounts for financial year 2025: profit of € 87,173 (▼ 18% vs 2024). Source: NBB ↗
2017 Birgit Martens became a director. NBB
Jul 26, 2002 New establishment in Oud-Heverlee. KBO
May 22, 2002 Start of the company according to the CBE. KBO

In short

From € 72,175 profit in 2022 to € 87,173 profit in 2025.

Paid € 168,909 in corporate taxes since 2022.

Best year ever: 2024, with € 106,714 profit.

Paid out € 268,800 in dividends to the owners in total.

Original PDFs at the National Bank ↗

Management

Birgit Martens

INTEGRAL HEALTH & RESEARCH

Behind INTEGRAL HEALTH & RESEARCH is Birgit Martens.

Directors

According to the 2025 annual accounts

Birgit Martens

Manager

since 2017

Establishments

Establishment units

Physical locations of this company

Registered office

Herpendaalstraat 47

3053 Oud-Heverlee

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0477.577.520

VAT number

BE 0477.577.520

Registered office

Herpendaalstraat 47, 3053 Oud-Heverlee

Names & denominations

INTEGRAL HEALTH & RESEARCH · iH&R

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Normale toestand

Start date

22 May 2002

Peppol

Active · Active since 4 Dec 2025

Activities · NACE

Overige technische testen en toetsen

Technische testen en analyses

Activiteiten van adviesbureaus op het gebied van bedrijfsvoering en overig managementadvies

Organisatie van congressen en beurzen

Overige adviesbureaus op het gebied van bedrijfsvoering en beheer

Organisatie van salons, tentoonstellingen en beurzen

Overige adviesbureaus op het gebied van bedrijfsbeheer; adviesbureaus op het gebied van bedrijfsvoering

View on CBE Public ↗ Annual accounts (NBB) ↗